Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/754| Title: | Management of male pattern hair loss. |
| Epworth Authors: | Sinclair, Rodney |
| Keywords: | Administration Adult Aged Alopecia Pathology Therapy Enzyme Inhibitors Therapeutic Use Finasteride Hair Transplantation Male Minoxidil Vasodilator Agents Androgenetic Alopecia AGA Male Pattern Baldness Male Pattern Hair Loss Department of Dermatology, Epworth Hospital, Richmond, Victoria, Australia |
| Issue Date: | Jul-2001 |
| Publisher: | Frontline Medical Communications Inc. |
| Citation: | Cutis. 2001 Jul;68(1):35-40. |
| Abstract: | The management of androgenetic alopecia (AGA) has been materially altered by the availability of the 5 alpha-reductase type 2 inhibitor, finasteride. Nevertheless, this agent is only one component of successful management, and an understanding of the role of camouflage agents, surgical options, and other medical treatments is important. Because no treatment completely reverses baldness, it is important to communicate the limitations of each modality to the patient so that he has appropriate expectations of the outcome of any intervention. Patient counseling and support are also often relevant. |
| URI: | http://hdl.handle.net/11434/754 |
| PubMed URL: | http://www.ncbi.nlm.nih.gov/pubmed/11480145 |
| ISSN: | 0011-4162 |
| Journal Title: | Cutis |
| Type: | Journal Article |
| Type of Clinical Study or Trial: | Review |
| Appears in Collections: | Dermatology Head & Neck |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.